CompletedNCT07450027
LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis
Observational studyAges 18–49TürkiyeSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 49 years.
- Listed locations
- ElâzığSee all locations and recruitment
Study information
Study start dateStarted: September 1, 2025
- Recruitment status
- Completed
- Enrollment listed in the registry
- 111
- Sponsor
- Elazığ Mental Health and Diseases Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Türkiye
- Age range
- From 18 Years to 49 Years
- Official registry ID
- NCT07450027
- Official title
Show the full official title
Serum LRFN5 and OLFM4 Levels in Methamphetamine Use Disorder and Methamphetamine-Induced Psychotic Disorder: A Cross-Sectional Case-Control Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Elâzığ, Türkiye · Türkiye
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Elazığ Mental Health and Diseases Hospital, a hospital or academic medical center.
Who was this study for?
Listed age limits: 18 years to 49 years.
